BiotechTube

Vinblastine + Cyclophosphamide + Capecitabine + Nivolumab

Phase 1/2Active
0 watching 0 views this week⚡ Active
40
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Childhood Solid Tumor

Conditions

Childhood Solid Tumor

Trial Timeline

Mar 26, 2019 → Jan 1, 2027

NCT ID
NCT03585465

About Vinblastine + Cyclophosphamide + Capecitabine + Nivolumab

Vinblastine + Cyclophosphamide + Capecitabine + Nivolumab is a phase 1/2 stage product being developed by Bristol Myers Squibb for Childhood Solid Tumor. The current trial status is active. This product is registered under clinical trial identifier NCT03585465. Target conditions include Childhood Solid Tumor.

Hype Score Breakdown

Clinical
13
Activity
8
Company
9
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT03585465Phase 1/2Active

Competing Products

20 competing products in Childhood Solid Tumor

See all competitors
ProductCompanyStageHype Score
LY2940680 + LY2940680Eli LillyPhase 1
33
Panobinostat + Cytarabine + PanobinostatNovartisPhase 1
33
Obinutuzumab + MMF + Prednisone + Methylprednisolone + Acetaminophen/ Paracetamol + Diphenhydramine HydrochlorideRochePhase 3
77
Rituximab + PlaceboRochePhase 2/3
65
BlinatumomabAmgenPhase 2
51
SemaglutideNovo NordiskApproved
84
Temsirolimus + Etoposide + Cyclophosphamide + Methotrexate + Hydrocortisone + CytarabinePfizerPhase 1
32
Talazoparib + Irinotecan + Temozolomide + Filgrastim + Peg-filgrastimPfizerPhase 1
32
CrizotinibPfizerPhase 1/2
40
Nivolumab + 5-azacytidineBristol Myers SquibbPhase 1/2
40
carboplatin + irinotecan hydrochlorideBristol Myers SquibbPhase 1
32
Paxalisib + Opdualag + Irinotecan (drug) + Temozolomide (TMZ)Bristol Myers SquibbPhase 1/2
40
Clofarabine incorporated into a 5-drug regimenSanofiPhase 1
32
Brivaracetam Film-coated tablet + Brivaracetam oral solutionUCBPhase 3
74
Brivaracetam Film-coated tablet + Brivaracetam oral solutionUCBPhase 3
74
BrivaracetamUCBPhase 3
74
Sodium OxybateJazz PharmaceuticalsPhase 1/2
38
Modified Measles Virus + Modified Measles Virus Lumbar PunctureBrain BiotechPhase 1
25
palbociclib isethionateBrain BiotechPhase 1
25
Cytarabine + Fludarabine + Hydrocortisone Sodium Succinate + Imetelstat + Leucovorin Calcium + MethotrexateGeronPhase 1
28

Other Products from Bristol Myers Squibb

DeucravacitinibApproved
84
Aripiprazole + Olanzapine + HaloperidolApproved
84
Irbesartan + CiprofibrateApproved
84
Entecavir + Lamivudine Placebo + Lamivudine + Entecavir PlaceboApproved
84
deucravacitinibApproved
84